Citation: M. Gold et al., PLASMA THIAMINE-DEFICIENCY ASSOCIATED WITH ALZHEIMERS-DISEASE BUT NOTPARKINSONS-DISEASE, Metabolic brain disease, 13(1), 1998, pp. 43-53
Authors:
HAUSER RA
MOLHO E
SHALE H
PEDDER S
DORFLINGER EE
Citation: Ra. Hauser et al., A PILOT EVALUATION OF THE TOLERABILITY, SAFETY, AND EFFICACY OF TOLCAPONE ALONE AND IN COMBINATION WITH ORAL SELEGILINE IN UNTREATED PARKINSONS-DISEASE PATIENTS, Movement disorders, 13(4), 1998, pp. 643-647
Authors:
KORDOWER JH
FREEMAN TB
CHEN EY
MUFSON EJ
SANBERG PR
HAUSER RA
SNOW B
OLANOW CW
Citation: Jh. Kordower et al., FETAL NIGRAL GRAFTS SURVIVE AND MEDIATE CLINICAL BENEFIT IN A PATIENTWITH PARKINSONS-DISEASE, Movement disorders, 13(3), 1998, pp. 383-393
Citation: Ra. Hauser et al., SUCCESSFUL TREATMENT OF A PATIENT WITH SEVERE REFRACTORY MYASTHENIA-GRAVIS USING MYCOPHENOLATE-MOFETIL, Neurology, 51(3), 1998, pp. 912-913
Authors:
SETHI KD
OBRIEN CF
HAMMERSTAD JP
ADLER CH
DAVIS TL
TAYLOR RL
SANCHEZRAMOS J
BERTONI JM
HAUSER RA
Citation: Kd. Sethi et al., ROPINIROLE FOR THE TREATMENT OF EARLYPARKINSON-DISEASE - A 12-MONTH EXPERIENCE, Archives of neurology, 55(9), 1998, pp. 1211-1216
Authors:
ADLER CH
SINGER C
OBRIEN C
HAUSER RA
LEW MF
MAREK KL
DORFLINGER E
PEDDER S
DEPTULA D
YOO K
Citation: Ch. Adler et al., RANDOMIZED, PLACEBO-CONTROLLED STUDY OF TOLCAPONE IN PATIENTS WITH FLUCTUATING PARKINSON-DISEASE TREATED WITH LEVODOPA-CARBIDOPA, Archives of neurology, 55(8), 1998, pp. 1089-1095
Authors:
KOMPOLITI K
GOETZ CG
BOEVE BF
MARAGANORE DM
AHLSKOG JE
MARSDEN CD
BHATIA KP
GREENE PE
PRZEDBORSKI S
SEAL EC
BURNS RS
HAUSER RA
GAUGER LL
FACTOR SA
MOLHO ES
RILEY DE
Citation: K. Kompoliti et al., CLINICAL PRESENTATION AND PHARMACOLOGICAL THERAPY IN CORTICOBASAL DEGENERATION, Archives of neurology, 55(7), 1998, pp. 957-961
Authors:
BLOCK G
LISS C
REINES S
IRR J
NIBBELINK D
AARLI J
AGUILAR M
AHRENS S
BAKHEIT A
BAUMEL B
BERTONI J
CAPILDEO R
CASTROCALDAS A
DEZA L
DONALDSON I
FRANCK G
FUSILLO J
GAUTHIER S
GERSHANIK O
GRANERUS AK
HAUSER RA
HENNESSEY K
HUTTON JT
JOFFE R
KOLLER W
LAST B
LEWITT P
MAMOLI B
MANYAM B
MARK M
NAKANO K
NAUSIEDA P
OTERO E
PAULSON G
PINTER M
REICH S
RODNITZKY R
SAGE J
SAMPAIO C
SMITH B
TERAVAINEN H
TETRUD J
TOLOSA E
ULM G
VALESCO F
Citation: G. Block et al., COMPARISON OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE CARBIDOPA LEVODOPA IN PARKINSONS-DISEASE - A MULTICENTER 5-YEAR STUDY/, European neurology, 37(1), 1997, pp. 23-27
Authors:
BORLONGAN CV
POLGAR S
FREEMAN TB
HAUSER RA
CAHILL DW
SANBERG PR
Citation: Cv. Borlongan et al., WILL FETAL STRIATAL TRANSPLANTS CORRECT THE AKINETIC END-STAGE OF HUNTINGTONS-DISEASE, Neurodegeneration, 5(2), 1996, pp. 189-192
Authors:
KOMPOLITI K
GOETZ C
MARAGANORE DM
BOEVE BF
MARSDEN CD
BHATIA KP
GREENE PE
PRZEDBORSKI S
SEAL ECJ
BURNS RS
HAUSER RA
GAUGER I
FACTOR SA
MOLHO ES
RILEY DE
Citation: K. Kompoliti et al., CLINICAL PRESENTATION AND PHARMACOLOGICAL THERAPY IN CORTICO-BASAL GANGLIONIC DEGENERATION, Annals of neurology, 40(3), 1996, pp. 171-171
Authors:
HAUSER RA
ZESIEWICZ TA
MARTINEZ C
ROSEMURGY AS
OLANOW CW
Citation: Ra. Hauser et al., BLOOD MANGANESE CORRELATES WITH BRAIN MAGNETIC-RESONANCE-IMAGING CHANGES IN PATIENTS WITH LIVER-DISEASE, Canadian journal of neurological sciences, 23(2), 1996, pp. 95-98
Citation: Cv. Borlongan et al., CYCLOSPORINE-A INCREASES LOCOMOTOR-ACTIVITY IN RATS WITH 6-HYDROXYDOPAMINE-INDUCED HEMIPARKINSONISM - RELEVANCE TO NEURAL TRANSPLANTATION, Surgical neurology, 46(4), 1996, pp. 384-388
Citation: Ra. Hauser et al., EXCESS MOLAR ENTHALPIES OF 6 (CARBON-DIOXIDE PLUS A POLAR-SOLVENT) MIXTURES AT THE TEMPERATURES 298.15 K AND 308.15 K AND PRESSURES FROM 7.5 MPA TO 12.6 MPA, Journal of Chemical Thermodynamics, 28(11), 1996, pp. 1303-1317
Authors:
OLANOW CW
HAUSER RA
GAUGER L
MALAPIRA T
KOLLER W
HUBBLE J
BUSHENBARK K
LILIENFELD D
ESTERLITZ J
Citation: Cw. Olanow et al., THE EFFECT OF DEPRENYL AND LEVODOPA ON THE PROGRESSION OF PARKINSONS-DISEASE, Annals of neurology, 38(5), 1995, pp. 771-777